Oxler Private Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.16M | Buy |
17,002
+147
| +0.9% | +$27.3K | 0.99% | 22 |
|
|
2025
Q1 | $3.53M | Buy |
16,855
+140
| +0.8% | +$29.3K | 1.24% | 23 |
|
|
2024
Q4 | $2.97M | Buy |
16,715
+44
| +0.3% | +$7.82K | 0.98% | 23 |
|
|
2024
Q3 | $3.29M | Buy |
16,671
+133
| +0.8% | +$26.3K | 1.15% | 23 |
|
|
2024
Q2 | $2.84M | Buy |
16,538
+158
| +1% | +$27.1K | 1.05% | 24 |
|
|
2024
Q1 | $2.98M | Buy |
16,380
+13,122
| +403% | +$2.39M | 1.17% | 22 |
|
|
2023
Q4 | $505K | Sell |
3,258
-12,788
| -80% | -$1.98M | 0.42% | 42 |
|
|
2023
Q3 | $2.39M | Buy |
16,046
+142
| +0.9% | +$21.2K | 1.2% | 24 |
|
|
2023
Q2 | $2.14M | Sell |
15,904
-42
| -0.3% | -$5.66K | 1.02% | 28 |
|
|
2023
Q1 | $2.54M | Buy |
15,946
+151
| +1% | +$24.1K | 1.25% | 24 |
|
|
2022
Q4 | $2.55M | Buy |
+15,795
| New | +$2.55M | 1.37% | 25 |
|
|
2022
Q3 | – | Sell |
-15,495
| Closed | -$2.37M | – | 435 |
|
|
2022
Q2 | $2.37M | Buy |
15,495
+149
| +1% | +$22.8K | 1.14% | 26 |
|
|
2022
Q1 | $2.49M | Buy |
15,346
+148
| +1% | +$24K | 1.12% | 25 |
|
|
2021
Q4 | $2.06M | Hold |
15,198
| – | – | 0.85% | 33 |
|
|
2021
Q3 | $1.64M | Hold |
15,198
| – | – | 0.72% | 38 |
|
|
2021
Q2 | $1.71M | Hold |
15,198
| – | – | 0.75% | 41 |
|
|
2021
Q1 | $1.64M | Buy |
15,198
+4,473
| +42% | +$484K | 0.83% | 34 |
|
|
2020
Q4 | $1.15M | Buy |
+10,725
| New | +$1.15M | 0.65% | 36 |
|